Key result
Relaxation training increases headache-free days and reduces severity vs waitlist control at 51 months.
Why the study?
The long-term effects of relaxation training for pediatric headache disorders were not well established.
Does relaxation training improve headache activity in pediatric headache disorders?
RCT (n=17)
random assignment
Does relaxation training improve headache activity in pediatric headache disorders?
Relaxation training provides long-term benefits in reducing headaches originating in childhood.
Long-term headache increases followed pediatric relaxation training; leaves open durability of benefits and need for maintenance strategies.
The long-term effects of relaxation training for pediatric headache disorders was determined for 17 of 20 original participants from a prospective control-group experimental design study with random assignment to autogenic relaxation, progressive relaxation, autogenic plus progressive relaxation, or waiting list control groups. Long-term follow-up data were obtained at an average of 51 months post-treatment. All participants reported some increases in headache activity. Participants in the three relaxation treatment groups, however, had significantly more headache-free days and less severe headaches compared to the control group. There were no significant effects of treatment for headache duration, medication intake and rest time due to headache. Twelve of the 13 treated participants indicated relaxation training was effective in relieving headaches, with 7 reporting they practiced relaxation exercises within the past month. The results generally support the long-term benefits of relaxation in reducing headaches originating in childhood.
No takes yet. Share an insight, caveat, or question.
Engel et al. (1992) conducted an RCT in pediatric headache disorders (n=17). Relaxation training vs. waiting list control was evaluated on headache-free days and headache severity. Relaxation training resulted in significantly more headache-free days and less severe headaches compared to a waiting list control group at an average of 51 months post-treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: